The case for & against
Bull & Bear analysis
Bullish
Astrana Health (formerly known as Apollo Medical Holdings, Inc., ticker: ASTH) is a leading healthcare technology and management company that specializes in providing physician-centric, AI-enabled healthcare solutions. The company operates within the healthcare management space, focused on improving patient care quality and operational efficiencies through its proprietary technology. Astrana Health’s model emphasizes collaboration among physicians, making it well-positioned to capitalize on the growing trends of digital health and patient-centered care in an evolving healthcare landscape.
Bull says
- ↑Q2 2026 revenue $972.5M (+49% YoY), net income $18.5M (+81%).
- ↑YTD free cash flow of $92.9M underpins financial flexibility.
- ↑Q3 2026 guidance: revenue $1.0B–$1.03B, adj. EBITDA $72.5M–$77.5M.
- ↑Median price target $52 implies 33.5% upside; consensus buy.
- ↑Digital health growth and patient-centric care trends drive demand.
- ↑High earnings yield, strong FCF/EV ratio, ROE of 66.6% indicates profitability.
Bear says
- ↓Intensifying digital health competition may compress margins and share.
- ↓Scaling complexity risks: slow provider adoption could limit revenue.
- ↓Analyst sentiment varies; forecast volatility may hurt investor confidence.
- ↓Economic downturn risks could impair cash flow and operations.
- ↓Current valuation may be stretched amid potential sector headwinds.
- ↓Negative earnings yield, poor profitability, high short interest, weak FCF/EV.